Indication

Progressive keratoconus

Progressive keratoconus is an active, worsening corneal ectatic disorder affecting the ocular system, most commonly emerging in adolescence or early adulthood. Read more about Progressive keratoconus

6 drugs 2 manufacturers

Advertisement

Drugs that treat it

Common Progressive keratoconus therapies.

Showing 1–6 of 6 drugs

Filter & compare in the drug finder →Opens the drug finder with Progressive keratoconus preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Progressive keratoconus.

Progressive keratoconus is an active, worsening corneal ectatic disorder affecting the ocular system, most commonly emerging in adolescence or early adulthood.

It is characterized by continuing biomechanical instability and degradation of the corneal stroma, resulting in noninflammatory structural thinning and conical protrusion of the central or paracentral cornea.

Clinically, active progression is confirmed through serial topography or tomography demonstrating documented increases in corneal steepening, progressive stromal thinning, and worsening irregular astigmatism and myopia.

Left unchecked, this progression causes advancing visual distortion, diminished best-corrected visual acuity, and potentially debilitating corneal scarring.

Personalize your experience

Follow Progressive keratoconus and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it